Neurocrine Biosciences, Inc.
Substituted triazoles and methods relating thereto
Last updated:
Abstract:
Substituted 1,2,3-triazole compounds are disclosed which have utility in the treatment of a variety of neurological disorders. The compounds provided herein have the general structure: ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3 and n are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound provided herein in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for treating neurological disorders in a subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
4 Jun 2020
Issue date:
1 Jun 2021